MedPath

Verification of safety and efficacy of plasmalogen and elastin combined formulation in cognitive functio

Not Applicable
Conditions
subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage,
Registration Number
JPRN-jRCTs041210012
Lead Sponsor
Ono Ken
Brief Summary

Plasmalogens and elastin containing food showed no significant efficacy for the improvement of cognitive function in total number of healthy elderly subjects (over 65 years old) participated in the present study, but it improved significantly the cognitive function in such subjects who showed mild memory impairment and forgetfulness.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
189
Inclusion Criteria

1) The subjects who are Male and Femaile over 65 who are aware of forgetfulness.
2) The subjects who displayed 24 scores or more of MMSE-J

Exclusion Criteria

1) The subjects who are likely to have allergy symptoms due to test ingredients.
2) The subjects who were diagnosed as patients with dementia
3) The subjects who received surgical operation for stroke, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage, cerebral contusion injury Head trauma Those with the inpatient surgery.
4) The subjects with medical history of epilepsy or diabetes and/or receiving medical treatment presently.
5) The subjects who is taking medicines (antipsychotic drugs, anxiolytics, antidepressants, antiparkinsonian drugs, antidepressants, antiepileptic drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Japanese version of River Mead Behavior Memory Test
Secondary Outcome Measures
NameTimeMethod
Clinical Assessment for Attention-Visual Cancellation Task, MOS 36-Item Short-Form Health Survey, AGE Reader-Advanced Glycation End-products,
© Copyright 2025. All Rights Reserved by MedPath